US approves first medication for severe non-alcoholic fatty liver disease
Friday, 15 March 2024 The FDA has approved Rezdiffra, the first medication for severe non-alcoholic fatty liver disease, showing improvement in liver scarring in NASH patients. NASH affects millions, linked to health issues like high blood pressure and diabetes. Rezdiffra targets root causes of NASH, with common side effects of diarrhoea and nausea.
Avian influenza A(H5N1) is a type of flu virus that usually infects wild birds and can spread to domestic birds and other animals. It occasionally infects people, though it is extremely rare for it to..
Friday, 15 March 2024
![Avian Influenza A(H5N1)" [Video]](https://video.newsserve.net/300/v/20240402/1712039869-Avian-Influenza-H5N1-quot.jpg)
